Microskia Inc. is pleased to announce the award of an SBIR research grant from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) under the solicitation RFA-EB-10-002 for Development and Translation of Medical Technologies that Reduce Health Disparities. This Phase I award is for the development of a new technological platform that will enable CBC blood analysis for
children in health disparity populations using a compact, light-weight and cost-effective unit that can be operated by minimally trained personnel right at the point of care or in resource poor settings such as rural areas. This proposed platform will enable effective monitoring of anemia in children; neutropenia in children; assist in the evaluation for infections; screen newborns for anemia, neutropenia or infections with the use of very low blood volumes.
Microskia Inc. was founded in 2009 as a spinoff from UCLA. The mission of the company is to commercialize holographic microscopy and other advanced photonic technologies invented by Professor Aydogan Ozcan at UCLA and his research group. For more information please contact Dr. Neven Karlovac, CEO, at firstname.lastname@example.org, 310-897-2096